You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 2, February 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Record Survival of Siblings With Familial Mediterranean Fever, Phenotypes 1 and 2

Case of Renal Vein Thrombosis Complicating the Amyloidosis (Phenotype 2)

Baruch J. Hurwich, MD; Julius Schwartz, MD; Stanley Goldfarb, MD

Arch Intern Med. 1970;125(2):308-311.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Amyloidosis, often with a diagnostically suggestive distribution, eventually occurs in many cases of familial Mediterranean fever (FMF). It appears at variable times after the onset of classical attacks of abdominal pain and is not necessarily related to the frequency and number of the preceding episodes of abdominal pain. In a small number, amyloid is the earliest indication of disease and only subsequently do the characteristic symptoms of FMF become manifest.

Sohar et al1 described as phenotype 1 those cases in which the febrile painful attacks appeared first and phenotype 2, those in which amyloidosis appeared first. Of 114 patients with amyloidosis, 106 were phenotype 1 and 8 were phenotype 2. In five of the eight with phenotype 2, attacks of abdominal pain appeared later, while only in three did amyloid remain the sole manifestation. Follow up of these three was for a maximum of three years. Support for the . . . [Full Text PDF of this Article]


Author Affiliations

New York; Brooklyn, NY; New York

From the departments of medicine and pathology, Beth Israel Medical Center, New York, and the Department of Medi-; cine, Maimonides Medical Center, Brooklyn, NY.


Footnotes

Received for publication Jan 29, 1969; accepted June 2.

Reprint requests to 8635 21st Ave, Brooklyn, NY 11214 (Dr. Schwartz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.